School of Clinical Medicine

School of Clinical Medicine. It is the medical school of the University of Cambridge, forming a core component of the broader academic division. The school is globally renowned for integrating world-class biomedical research with clinical education, operating in close partnership with the National Health Service. Its primary clinical base is the Cambridge Biomedical Campus, one of the largest and most intensive biomedical research centres in Europe.

History

The origins of formal clinical medical training at Cambridge University date to the 19th century, with significant expansion following the Goodenough Report of 1944, which shaped modern medical education in Britain. A pivotal development was the establishment of the Clinical School in 1976, consolidating pre-clinical sciences from the School of Biological Sciences with hospital-based training. This integration was accelerated by the 1995 merger creating Cambridge University Hospitals NHS Foundation Trust, which unified Addenbrooke's Hospital with other local NHS services. The school's growth has been inextricably linked to the development of the Cambridge Biomedical Campus, a site that now also hosts the Medical Research Council Laboratory of Molecular Biology and the Wellcome Sanger Institute.

Academic programs

The school's flagship program is the standard Bachelor of Medicine, Bachelor of Surgery degree, following a pre-clinical tripos in Natural Sciences. It also offers an accelerated Graduate Entry Course for holders of a prior degree and contributes significantly to the University of Cambridge's Doctor of Philosophy programs in medical science. Postgraduate clinical training is provided through a wide array of Specialist registrar programs and academic Clinical fellowships. The school is a major contributor to the Core Medical Training framework and offers specialized master's degrees in fields like Translational medicine and Public health.

Research and innovation

Research is organized within several internationally recognized institutes, including the Cambridge Institute for Medical Research and the Cancer Research UK Cambridge Institute. The school has been a leader in Genomics, heavily involved in the Human Genome Project through the Wellcome Sanger Institute. Its scientists have made landmark contributions to understanding neurodegenerative diseases at the UK Dementia Research Institute and metabolic disorders at the Metabolic Research Laboratories. Pioneering work in Monoclonal antibody therapy and Stem cell biology has also originated here, with strong ties to the Babraham Institute and the European Bioinformatics Institute.

Clinical training and facilities

Primary clinical training occurs across the Cambridge University Hospitals NHS Foundation Trust, principally at Addenbrooke's Hospital and the Royal Papworth Hospital, the UK's leading cardiothoracic centre. Students also gain experience at regional NHS Trusts including West Suffolk Hospital and Peterborough City Hospital. The school utilizes advanced simulation facilities at the Clinical Skills Centre and the Mary Marlborough Lodge for disability assessment training. Its location on the Cambridge Biomedical Campus provides direct exposure to the Rosie Hospital for maternity care and the Cambridge Children's Hospital project.

Faculty and leadership

The school has been led by notable figures such as Sir Keith Peters and current Regius Professor Patrick Maxwell. Its faculty includes numerous Fellows of the Royal Society like John Bell and Fellows of the Academy of Medical Sciences such as Fiona Watt. Past influential faculty include Sir William Hardy and Sir Roy Calne, a pioneer in Organ transplantation. Many professors hold joint appointments with major research institutes, including the Medical Research Council and the Wellcome Trust.

Affiliations and partnerships

The school's principal NHS partnership is with the Cambridge University Hospitals NHS Foundation Trust. It maintains strong research alliances with the Medical Research Council Laboratory of Molecular Biology, the Wellcome Sanger Institute, and the European Molecular Biology Laboratory. It is a key partner in the Cambridge University Health Partners academic health science centre. International collaborations are extensive, involving institutions like the National Institutes of Health and the Max Planck Society. The school also works closely with pharmaceutical and biotech industries clustered in the Cambridge phenomenon ecosystem.